Status:

COMPLETED

Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension.

Lead Sponsor:

Bayer

Conditions:

Hypertension, Pulmonary

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

This study is to demonstrate the safety, tolerability, pharmakokinetic and pharmacodynamic effect of a single oral dose of BAY63-2521 in patients with pulmonary hypertension due to chronic obstructive...

Detailed Description

In addition to the pharmacodynamic and pharmacokinetic variables, the following laboratory variables were assessed: * Hematology: Leucocytes, erythrocytes, hemoglobin, hematocrit, mean corpuscular vo...

Eligibility Criteria

Inclusion

  • Patients with pulmonary hypertension due to COPD, undergoing routine invasive measurement of hemodynamic parameters.
  • Catheters for measurement of hemodynamic parameters (PAP \[pulmonary artery pressure\], PCWP \[pulmonary capillary wedge pressure\], CO \[cardiac output\], SBP \[systolic blood pressure\]) must be in place independent of the trial.

Exclusion

  • Acute exacerbation of COPD,
  • Pre-existing lung disease other than COPD,
  • Acute or severe chronic left heart failure,
  • Severe coronary artery disease,
  • Uncontrolled arterial hypertension;
  • Severe left ventricular hypertrophy,
  • Congenital or acquired valvular or myocardial disease,
  • Systolic blood pressure \< 100 mmHg,
  • Heart rate \< 55 bpm or \>105 bpm,
  • PaO2 (arterial partial oxygen pressure)/FiO2 (fraction of inspired oxygen) \< 50 mmHg,
  • PaCO2 (arterial partial pressure of carbon dioxide) \> 55 mmHg,
  • Severe hepatic insufficiency,
  • Severe renal insufficiency.

Key Trial Info

Start Date :

August 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2009

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT00640315

Start Date

August 1 2008

End Date

September 1 2009

Last Update

December 28 2016

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Heidelberg, Baden-Wurttemberg, Germany, 69126

2

Löwenstein, Baden-Wurttemberg, Germany, 74245

3

München, Bavaria, Germany, 81377

4

Bad Nauheim, Hesse, Germany, 61231

Single Dose Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) Associated Pulmonary Hypertension. | DecenTrialz